| Market Cap | ₹62Cr |
| ROE | 1.95% |
| P/E Ratio(TTM) | 12.44 |
| EPS(TTM) | 2.73 |
| P/B Ratio | 1.11 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.81 |
| Book Value | 30.68 |
| Debt to Equity | 0.29 |
| Face Value | 10 |
| Parent Organisation | Onyx Biotec |
| NSE Symbol | ONYX |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |